Propranolol

"Propranolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.

Descriptor ID	D011433
MeSH Number(s)	D02.033.100.624.698.711 D02.033.755.624.698.711 D02.092.063.624.698.711 D02.455.426.559.847.638.945 D04.615.638.945
Concept/Terms	Propranolol Propranolol Propanolol Inderal Inderal Avlocardyl Avlocardyl AY-20694 AY-20694 AY 20694 AY20694 Rexigen Rexigen Dexpropranolol Dexpropranolol Dociton Dociton Obsidan Obsidan Obzidan Propranolol Hydrochloride Propranolol Hydrochloride Hydrochloride, Propranolol Anaprilin Anaprilin Anapriline Betadren Betadren

Below are MeSH descriptors whose meaning is more general than "Propranolol".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Alcohols [D02.033]
Amino Alcohols [D02.033.100]
Propanolamines [D02.033.100.624]
Phenoxypropanolamines [D02.033.100.624.698]
Propranolol [D02.033.100.624.698.711]
Propanols [D02.033.755]
Propanolamines [D02.033.755.624]
Phenoxypropanolamines [D02.033.755.624.698]
Propranolol [D02.033.755.624.698.711]
Amines [D02.092]
Amino Alcohols [D02.092.063]
Propanolamines [D02.092.063.624]
Phenoxypropanolamines [D02.092.063.624.698]
Propranolol [D02.092.063.624.698.711]
Hydrocarbons [D02.455]
Hydrocarbons, Cyclic [D02.455.426]
Hydrocarbons, Aromatic [D02.455.426.559]
Polycyclic Aromatic Hydrocarbons [D02.455.426.559.847]
Naphthalenes [D02.455.426.559.847.638]
Propranolol [D02.455.426.559.847.638.945]
Polycyclic Compounds [D04]
Polycyclic Aromatic Hydrocarbons [D04.615]
Naphthalenes [D04.615.638]
Propranolol [D04.615.638.945]

Below are MeSH descriptors whose meaning is more specific than "Propranolol".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Propranolol" by people in this website by year, and whether "Propranolol" was a major or minor topic of these publications.

Bar chart showing 15 publications over 9 distinct years, with a maximum of 4 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	0	2
2006	0	1	1
2007	0	1	1
2008	0	1	1
2009	2	2	4
2010	0	2	2
2017	1	0	1
2019	1	0	1
2021	0	2	2

Below are the most recent publications written about "Propranolol" by people in Profiles.

Rivera-Ortiz J, Pla-Tenorio J, Cruz ML, Colon K, Perez-Morales J, Rodriguez JA, Martinez-Sicari J, Noel RJ. Blockade of beta adrenergic receptors protects the blood brain barrier and reduces systemic pathology caused by HIV-1 Nef protein. PLoS One. 2021; 16(11):e0259446.

View in: PubMed
Giorgio CMR, Licata G, Briatico G, Babino G, Fulgione E, Gambardella A, Alfano R, Argenziano G. Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma. Int J Dermatol. 2021 May; 60(5):631-633.

View in: PubMed
Montoya A, Varela-Ramirez A, Dickerson E, Pasquier E, Torabi A, Aguilera R, Nahleh Z, Bryan B. The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer. Biomed J. 2019 06; 42(3):155-165.

View in: PubMed
Montoya A, Amaya CN, Belmont A, Diab N, Trevino R, Villanueva G, Rains S, Sanchez LA, Badri N, Otoukesh S, Khammanivong A, Liss D, Baca ST, Aguilera RJ, Dickerson EB, Torabi A, Dwivedi AK, Abbas A, Chambers K, Bryan BA, Nahleh Z. Use of non-selective ?-blockers is associated with decreased tumor proliferative indices in early stage breast cancer. Oncotarget. 2017 Jan 24; 8(4):6446-6460.

View in: PubMed
Otis JM, Mueller D. Inhibition of ?-adrenergic receptors induces a persistent deficit in retrieval of a cocaine-associated memory providing protection against reinstatement. Neuropsychopharmacology. 2011 Aug; 36(9):1912-20.

View in: PubMed
Tzingounis AV, von Zastrow M, Yudowski GA. {Beta}-blocker drugs mediate calcium signaling in native central nervous system neurons by {beta}-arrestin-biased agonism. Proc Natl Acad Sci U S A. 2010 Dec 07; 107(49):21028-33.

View in: PubMed
Devanga-Chinta D, Graves RA, Pamujula S, Mandal TK. Controlled release multiple layer coatings. Drug Dev Ind Pharm. 2010 Feb; 36(2):200-8.

View in: PubMed
Ajmo CT, Collier LA, Leonardo CC, Hall AA, Green SM, Womble TA, Cuevas J, Willing AE, Pennypacker KR. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol. 2009 Jul; 218(1):47-55.

View in: PubMed
Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, Nick AM, Stone RL, Lu C, Lutgendorf SK, Cole SW, Lokshin AE, Sood AK. Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res. 2009 Apr 15; 15(8):2695-702.

View in: PubMed
Rodriguez-Romaguera J, Sotres-Bayon F, Mueller D, Quirk GJ. Systemic propranolol acts centrally to reduce conditioned fear in rats without impairing extinction. Biol Psychiatry. 2009 May 15; 65(10):887-92.

View in: PubMed

People

Explore

Similar Concepts

Top Journals